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Jing Yuan Luan, MD, Xuan Li, MD, Tian Run Li, MD, Guo Jun Zhai, MD, and Jin Tao Han, MD,
Beijing, China
Objective: We report our experience in the treatment of isolated superior mesenteric artery dissection and review the
clinical and imaging features reported in the literature.
Methods: A retrospective study was conducted of 18 consecutive patients with isolated superior mesenteric artery
dissection who presented at the Peking University Third Hospital between September 2008 and May 2012. Their clinical
characteristics, including age, sex, medical history, risk factors, symptoms, diagnostic imaging modality, and treatment,
were analyzed. Also reviewed were 278 patients with isolated superior mesenteric artery dissection reported in the English
language literature. The epidemiology, mechanism, clinical presentation, imaging features, and treatment were discussed.
Results: There were 14 men and four women with a mean age of 55.6 years (range, 41-84 years). Four patients were
asymptomatic, and 14 presented with acute-onset abdominal pain. The diagnosis was established by contrast-enhanced
computed tomography in 17 patients and ultrasound imaging in one patient. All dissections were located at the ante-
rior wall and around the convex curvature of the superior mesenteric artery. The decision to intervene was based on
symptoms. Three asymptomatic patients underwent successful conservative management, and one asymptomatic patient
with an aneurysmal dilated false lumen underwent endovascular stent placement. For the 14 symptomatic patients,
deﬁnitive treatment included catheter-directed infusion of a vasodilator in four and stent placement combined with
catheter-directed infusion of a vasodilator in 10, of whom one patient underwent hybrid stent placement. No compli-
cations or deaths occurred. During the mean 14.9-month (range, 1-40 month) follow-up period, all patients were
asymptomatic, and patency of the superior mesenteric artery was demonstrated by contrast-enhanced computed
tomography scan.
Conclusions: Conservative management can be applied to asymptomatic patients with isolated superior mesenteric artery
dissection. For symptomatic patients, stent placement is the deﬁnitive treatment if there is no arterial rupture or intestinal
necrosis. Self-expanding bare stents that completely cover the curvature of the superior mesenteric artery are recom-
mended. Catheter-directed infusion of a vasodilator can be an effective accessional process after stent placement. (J Vasc
Surg 2013;57:1612-20.)Isolated superior mesenteric artery dissection that is
not associated with aortic dissection is notably rare. The
epidemiology, etiology, mechanism, clinical, and imaging
features have not been fully investigated. In addition, there
is no consensus on the optimal management strategy. We
report 18 patients with isolated superior mesenteric artery
dissection and present a review of 278 patients with iso-
lated superior mesenteric artery dissection reported in the
English-language literature and discuss the features and
treatment strategy.
METHODS
This retrospective study was approved by the Institu-
tional Review Board. We reviewed the medical records of
18 consecutive patients with isolated superior mesentericthe Department of Interventional Radiology and Vascular Surgery,
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2artery dissection who presented at the Peking University
Third Hospital between September 2008 and May 2012.
Their clinical characteristics, including age, sex, medical
history, risk factors, and symptoms, were analyzed. The
imaging ﬁndings, including location and length of dissec-
tion, and the percentage of true lumen compressed by
the false lumen, were evaluated by computed tomography
(CT) angiography. For asymptomatic patients, conserva-
tive treatment consisted of bowel rest and strict blood pres-
sure control to reduce systolic pressure to <120 mm Hg.
Patients who presented with abdominal pain under-
went urgent mesenteric arteriography. If the superior mes-
enteric artery was occlusive, a guidewire was advanced
through the dissected portion and into the distal trunk of
the superior mesenteric artery, and a bare stent was subse-
quently deployed. Next, a 4F end-hole catheter was
inserted into the superior mesenteric artery, and catheter-
directed infusion of papaverine (30 mg/h) was performed
for 24 hours. If the superior mesenteric artery was not
occlusive, catheter-directed infusion of papaverine was
performed ﬁrst. A bare stent was deployed if the pain
was aggravated or not relieved by the end of 24 hours.
Antiplatelet therapy was maintained with 100 mg aspirin
and 75 mg clopidogrel daily for 6 months postoperatively.
Clinical follow-up and CT surveillance were performed
periodically.
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The 18 patients (14 men, four women) were a mean
age of 55.6 years (range, 41-84 years). Four asymptomatic
patients were detected incidentally, and the other 14 pre-
sented with abdominal pain and epigastrium tenderness.
The accompanying symptoms included nausea (n ¼ 2),
vomiting (n ¼ 1), diarrhea (n ¼ 1), and bloody stool
(n ¼ 1). An epigastric bruit was audible in only one patient.
There was no peritonitis or shock.
The medical history in the 18 patients included hyper-
tension in 10 (55.6%), arteriosclerosis in four (22.2%), dia-
betes mellitus in three (16.7%), and coronary heart disease,
hyperlipidemia, peptic ulcer, and emaciation in two
patients (11.1%) each. Three patients were smokers, and
two patients had been involved in recent trafﬁc accidents
while wearing a seat belt. Results of laboratory tests were
within normal reference ranges, except for slight leukocy-
tosis in three patients and a high C-reactive protein level
in one patient.
Isolated superior mesenteric artery dissection was diag-
nosed by ultrasound imaging in one patient and by CT
angiography in the other 17. The dissection was located
at the anterior wall and around the convex curvature of
the superior mesenteric artery in all 18 patients. The
mean distance from the ostium of the superior mesenteric
artery to the beginning of the dissection was 11.1 mm
(range, 1.0-32.0 mm). Dissection was a mean length of
70.4 mm (range, 16.0-202.8 mm; Table I).
Conservative treatment was successful in three of the
four asymptomatic patients. The other patient had an aneu-
rysm of the superior mesenteric artery, which was 26 mm at
its largest diameter, and underwent placement of a self-
expanding bare stent. Follow-up CT after 19 months
showed the patency of the stent and remarkable shrinkage
of the aneurysm (Fig 1). Among the 14 patients who pre-
sented with abdominal pain, occlusion of the superior
mesenteric artery was diagnosed in three patients, who
underwent endovascular stent placement followed by
catheter-directed infusion of papaverine. Stenosis of the
superior mesenteric artery was diagnosed in the remaining
11 patients who where symptomatic. These patients under-
went catheter-directed infusion of papaverine as the initial
therapy. Catheter-directed infusion of papaverine alone
was successful in relieving symptoms in four patients,
whereas seven had persistent abdominal pain requiring
stent placement after the vasodilator infusion. No compli-
cations or deaths occurred. All patients were followed up.
During the mean 14.9-month (range, 1-40 months)
follow-up period, all patients were asymptomatic and
possessed a patent superior mesenteric artery, as demon-
strated by CT angiography.
DISCUSSION
Epidemiology. The superior mesenteric artery is the
most frequently affected visceral artery by dissection.
However, isolated superior mesenteric artery dissection is
notably rare. The reported incidence was 0.06% in a seriesof 6666 autopsy cases.1 The incidence is likely under-
estimated because of a lack of reliable clinical signs and
laboratory ﬁndings. We searched the English-language
literature using the terms “superior mesenteric artery”
and “dissection” in the OvidSP database. Including the
present 18 patients, 296 patients with isolated superior
mesenteric artery dissection have been reported since
Bauerﬁeld2 ﬁrst described the condition in 1947. From
that report until 1972, 11 patients were diagnosed at
autopsy, 35 patients were reported between 1975 and
2001, and 250 since 2002. More patients with isolated
superior mesenteric artery dissection have been reported in
recent years due to increasing use of contrast-enhanced CT
scans for investigating abdominal pain. Only two deaths
have been reported since 1972. One patient died of iso-
lated superior mesenteric artery dissection3 and another
died of acute hepatitis and multiple organ failure.4
Men comprised 84.2% (245 of 291, unavailable in ﬁve)
of the reported patients. The patients are relatively young,
with a mean age of 55.4 years (range, 30-87, unavailable in
7). Analysis of the demographic data shows that the most
patients have been reported in Korea (n ¼ 111), followed
by Japan (n ¼ 68), China (n ¼ 38), United States (n ¼
33), France (n ¼ 17), Italy (n ¼ 3), Switzerland (n ¼ 3),
Canada (n ¼ 3), India (n ¼ 2), Israel (n ¼ 2), Netherlands
(n ¼ 2), United Kingdom (n ¼ 1), Germany (n ¼ 1), Spain
(n ¼ 1), Sweden (n ¼ 1), Turkey (n ¼ 1), Brazil (n ¼ 1),
and unavailable (n ¼ 8). Altogether, isolated superior
mesenteric artery dissection is most prevalent in Asian
(n ¼ 222), followed by North American (n ¼ 36), Euro-
pean (n ¼ 29), and South American (n ¼ 1) countries.
Etiology and mechanism. Onlyﬁve of the 296patients
underwent pathologic examination. Medial ﬁbrodysplasia
was revealed in one patient.5 However, no histologic ab-
normality, such as medial necrosis, ﬁbromuscular dyspla-
sia, atherosclerosis, or arteritis, was observed in the other
four.3,6-8 Because a pathologic assessment was not obtained
in most patients, the exact cause of isolated superior
mesenteric artery dissection has not been identiﬁed. The
reported available potential risk factor included hypertension
(n ¼ 82), smoking (n ¼ 51), hyperlipidemia (n ¼ 20),
coronary heart disease (n ¼ 12), atherosclerosis (n ¼ 6),
diabetes mellitus (n ¼ 5), trafﬁc trauma caused by wearing
a seat belt (n ¼ 4), and iatrogenic trauma during intubation
(n¼ 3). However, healthy patients without clear risk factors
weremore prevalent. Although the rates of hypertension and
smoking were relatively high, no obvious etiologic factor was
found, and their roles in causing dissection was purely
conjectural.
The proximal retropancreatic portion of the superior
mesenteric artery is relatively ﬁxed, and the more distal
part can move, depending on changes of bowel position.
In the reported 82 patients for whom CT or angiography
images were available, the dissection was consistently lo-
cated at the anterior wall and around the convex curvature
of the superior mesenteric artery. On a computer-simulation
model, Park et al9 observed abnormal mechanical stresses
on the anterior wall of this portion of the superior
Table I. The clinical characteristics, imaging features and treatment of the present 18 patients with isolated dissection of
the superior mesenteric artery
Pt Sex Age Symptom Comorbidity
Diagnosis
conﬁrmed
by
Distance from
the SMA
ostium to the
beginning
of dissection,
mm
Length of
dissection,
mm
SMA
stenosis, % Management
Catheter-directed
infusion of a
vasodilator
Follow-up
period,
months
1 F 55 Asymptomatic Hypertension CTA 32.0 16.0 67 Conservative . 1
2 M 59 Asymptomatic . CTA 1.0 19.0 40 Conservative . 1
3 M 53 Asymptomatic . CTA 8.5 73.8 . Conservative . 40
4 M 76 Asymptomatic Hypertension CTA 23.4 30.3 67 ESP, Protégé GPSa
8 mm  80 mm
Papaverine
30 mg/h
19
5 M 46 Mild
abdominal
pain
Hypertension,
hyperlipidemia
CTA 1.0 156.0 39 Endovascular
spasmolysis
Papaverine
30 mg/h
21
6 M 42 Mild
abdominal
pain
Trafﬁc trauma
wearing a
seat belt
CTA 10.0 129.9 50 Endovascular
spasmolysis
Papaverine
30 mg/h
15
7 M 46 Severe
abdominal
pain
Hypertension,
smoking,
coronary
heart disease
CTA 24.0 32.4 56 Endovascular
spasmolysis
Papaverine
30 mg/h
21
8 M 41 Severe
abdominal
pain,
nausea
Hypertension,
atherosclerosis
CTA 24.6 112.3 90 Endovascular
spasmolysis
Papaverine
30 mg/h
10
9 M 45 Abdominal
pain,
emaciation
. CTA 9.3 84.0 80 ESP, Protégé GPS
6 mm 60 mm
and SMARTb
8 mm 40 mm
Papaverine
30 mg/h
16
10 M 54 Abdominal
pain,
emaciation
Atherosclerosis CTA 26.0 35.0 62% ESP, Astronc
6 mm 40 mm,
Protégé GPS
8 mm 40 mm
and E-Luminexxd
10 mm 40 mm
Papaverine
30 mg/h
2
11 M 56 Mild
abdominal
pain
Hypertension,
smoking
CTA 1.0 202.8 59% ESP, Preciseb
7 mm  40 mm
Papaverine
30 mg/h
13
12 F 66 Mild
abdominal
pain
Hypertension CTA 7.0 27.3 63% ESP, Protégé GPS
8 mm  40 mm
Papaverine
30 mg/h
8
13 F 84 Mild
abdominal
pain
Hypertension,
diabetes
mellitus
CTA 7.3 26.4 55% ESP, Protégé GPS
7 mm  60 mm
Papaverine
30 mg/h
10
14 M 54 Severe
abdominal
pain
Hypertension,
smoking,
diabetes
mellitus
Ultrasound
imaging
7.2 64.8 69% ESP, Luminexx 3d
8 mm  40 mm
Papaverine
30 mg/h
15
15 F 71 Severe
abdominal
pain,
diarrhea
Hypertension CTA 1.0 38.0 90% ESP, Astron Pulsarc
4 mm  40 mm
Papaverine
30 mg/h
10
16 M 48 Severe
abdominal
pain
Coronary heart
disease
CTA 1.0 100.0 Occlusive Hybrid stent
placement, Astron
7 mm 60 mm
and SMART
8 mm 80 mm
Papaverine
30 mg/h
22
17 M 58 Severe
abdominal
pain
Diabetes
mellitus
CTA 7.5 85.0 Occlusive ESP, Astron
7 mm  60 mm
Papaverine
30 mg/h
21 mo
18 M 46 Severe
abdominal
pain
Hyperlipidemia,
trafﬁc trauma
wearing a seat
belt
CTA 7.2 33.5 Occlusive ESP, Precise
8 mm  40 mm
Papaverine
30 mg/h
24 mo
CTA, Computed tomography angiography; ESP, endovascular stent placement; F, female; M, male; SMA, superior mesenteric artery.
aev3 Endovascular, Inc, Plymouth, Minn.
bCordis, Miami, Fla.
cBIOTRONIK SE & Co. KG, Berlin, Germany.
dBard Peripheral Vascular Inc, Tempe, Ariz.
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Fig 1. A 76-year-old man with spontaneous isolated dissection of the superior mesenteric artery who was asymptomatic
and detected incidentally. A and B, Contrast-enhanced computed tomography (CT) scan demonstrates the dissection
and the true lumen is compressed by the aneurysmal dilated false lumen (white arrows), which is 26 mm at the largest
diameter. C and D, Contrast-enhanced CT scan at 19 months after placement of a self-expanding 8-mm  80-mm bare
stent (Protégé GPS; ev3 Endovascular, Inc, Plymouth, Minn) shows the patency of the stent and remarkable shrinkage of
the dissecting aneurysm.
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 6 Luan et al 1615mesenteric artery, which may be an important factor in the
development of isolated superior mesenteric artery
dissection.
In addition, in cases of increased ﬂow or pressure in the
superior mesenteric artery, such as with hypertension, post-
prandial, stenosis or occlusion of the celiac artery, the
enhancing hemodynamic shearing forces could lead to
weakening of the artery wall. This effect may be another
possible mechanism of isolated superior mesenteric artery
dissection.
Occasionally, isolated superior mesenteric artery dissec-
tion might be caused by strangulation due to a seat belt in
a trafﬁc accident.10,11 Iatrogenic causes, such as endovascu-
lar processing or even only angiography, can lead to12 or
aggravate13 isolated superior mesenteric artery dissection.
The cause may be direct tear intimal by a wire or a catheter
or by rapid ﬂow of the contrast medium during angiog-
raphy. Therefore, a catheter with side holes at the tip
should be used to decrease the pressure and lessen jumping
of the catheter tip.12Clinical presentation. The clinical presentation of iso-
lated superior mesenteric artery dissection ranges from
asymptomatic to acute peritonitis. In the 296 patients re-
ported, 231 (78.0%) reported abdominal pain, which was
the most common symptom. The cause of the abdominal
pain is intestinal ischemia, intestinal spasm, dissection itself,
or an inﬂammatory response that stimulates the visceral
nerve plexus. Other atypical accompanying symptoms
included nausea in 27 (9.1%), vomiting in 21 (7.1%), ileus
in 11 (3.7%), bloody stool in 10 (3.4%), diarrhea in eight
(2.7%), and emaciation in six (2.0%). The dissection was
detected incidentally in 47 asymptomatic patients (15.9%).
On physical examination, patients are usually tender to
palpation in the epigastrium or left upper quadrant.
Although Froment et al14 reported an audible bruit in
17.2% (5 of 29) of patients, the rate is only 3.0% (9 of
296) in our review. In laboratory tests, leukocytosis is
revealed in 32.5% (27 of 83) of available patients, and
a high level of C-reactive protein is noted in 22.7% (10
of 44) of available patients. Results of other laboratory
Fig 2. A 46-year-old man with isolated dissection of the superior mesenteric artery who was involved in recent trafﬁc
accident while wearing a seat belt. A, Contrast-enhanced computed tomography (CT) scan demonstrates isolated
dissection of the superior mesenteric artery and the true lumen is stenosis compressed by the false lumen. B, After 2
hours, angiography shows occlusion of the superior mesenteric artery. C, After the placement of an 8-mm  40-mm
Precise stent (Cordis, Miami, Fla), the angiography shows the superior mesenteric artery is patent.
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ported infrequently in the 296 patients were intestinal
necrosis in 10 (3.4%),1-3,15-20 rupture of the superior
mesenteric artery in six (2.0%),7,18,19,21-23 and pancreatitis
in two (0.7%).5,24
Diagnosis modality. Except for 14 unavailable
patients, 244 (86.5%) were diagnosed by contrast-
enhanced CT, 13 (4.6%) by angiography, 12 (4.3%) by
autopsy, 11 (3.9%) by ultrasound imaging, one (0.4%) by
magnetic resonance, and one (0.4%) by intravascular ultra-
sound imaging. Ultrasound imaging is helpful in identifying
the intimal ﬂap and the entry or reentry points.25 However,
this technique has limited utility in obese patients and in
patients with considerable bowel gas, and the diagnosis may
be missed.3 Contrast-enhanced CT ﬁndings of isolated
superior mesenteric artery dissection include intimal ﬂap,
mural thrombus, or intramural hematoma. Because the
intimal ﬂap is not always noticeable, the mural thrombus or
eccentric stenosis is the important indication of isolated
superior mesenteric artery dissection. Other CT ﬁndings
suggestive of dissection include an enlarged diameter and
increased attenuation of the fat around the superior
mesenteric artery, which may be the only nonspeciﬁc key
during the early stage.18 In the 121 available patients, the
mean distance from the ostium of the superior mesenteric
artery to the beginning of the dissection was 17.4 mm
(range, 1-60 mm), where it is just around the curvature of
the superior mesenteric artery. The mean length of dissec-
tion was 60.4 mm (range, 10-221 mm) in 140 available
patients. Besides these indications, CT is helpful in choosing
treatment method by revealing signs of intestinal ischemia
(lack of bowel wall enhancement) or necrosis (mesentericor portal venous gas). Because of its convenience, low
invasiveness, and reliability, contrast-enhanced CT has
proven to be the best diagnosis and surveillance modality for
isolated superior mesenteric artery dissection.
Management. The treatment aim of isolated superior
mesenteric artery dissection is symptom relief and prevention
of intestinal necrosis. Treatment options include conserva-
tive, surgical, or endovascular procedures. However, no
consensus guidelines are currently available.
Conservative treatment includes bowel rest and antihy-
pertensive therapy with or without anticoagulation. The
most conservatively treated patients were reported by
Park et al,26 who reported that the false lumen was dimin-
ished 41.3% in extent and 23.9% in length and completely
remodeled in 15.2% of 46 patients with isolated superior
mesenteric artery dissection during an average 23.0 months
of follow-up. The same year, Cho et al27 reported complete
resolution in 26.7%, improvement in 26.7%, and no change
in 46.7% of 15 patients with isolated superior mesenteric
artery dissection during an average of 15.6 months of CT
follow-up.
Successful conservative treatment with anticoagulation
was ﬁrst achieved by Ambo et al28; however, a prolonged
fasting period is required. The rationale of anticoagulation
is to prevent thrombosis and possible distal embolization.
However, anticoagulation does not halt the progression of
the dissection (Fig 2) and aneurysmal enlargement in
certain patients.29 Sheldon et al30 reported failure of antico-
agulation in one patient. The follow-up CT angiography
images revealed gradual and progressive worsening of
dissection. By 9 months, the false lumen increased 46% in
diameter, and the true lumen decreased 33% in diameter.
Table II. Themanagement of isolated dissection of the superior mesenteric artery reported in literature and the present cases
Primary
management Pt
Success,
No. (%)
Failure,
No. (%)
Secondary management (for failures)
Conservative,
without
anticoagulation,
No.
Conservative,
with
anticoagulation,
No.
Surgical
recanalization,
No.
Endovascular,
No.
Enterectomy,
No.
Hybrid
recanalization,
No.
Conservatively
Without
anticoagulation
152 112 (73.7) 40 (26.3)a 6 6 13 1 1
With
anticoagulation
57 44 (77.2) 13 (22.8) 4 8 1
Enterectomy
at the onset
2 2 (100.0) 0 (0.0)
Surgical
recanalization
33 32 (97.0) 1 (3.0) 1
Balloon
angioplasty
1 1 (100.0) 0 (0.0)
Embolotherapy
of a ruptured
branch of SMA
1 1 (100.0) 0 (0.0)
Catheter-directed
infusion of a
vasodilator
2 2 (100.0) 0 (0.0)
Endovascular
stent placement
42 40 (95.2) 2 (4.8) 1 1
Hybrid
recanalization
1 1 (100.0) 0 (0.0)
Unavailable 5
SMA, Superior mesenteric artery.
aIn which 13 patients died and were diagnosed at autopsy.
Fig 3. A 48-year-old man with spontaneous isolated dissection of the superior mesenteric artery undergoes hybrid stent
placement. A, Angiography shows occlusion of the superior mesenteric artery. B, After an unsuccessful transfemoral
approach, a guidewire is inserted into the true lumen through a transmesenteric artery approach under laparotomy. C,
After the hybrid stent (Astron 7-mm  60-mm [BIOTRONIK SE & Co KG, Berlin, Germany] and SMART 8-mm 
80-mm [Cordis, Miami, Fla]) placement, angiography shows a patent superior mesenteric artery. D, Contrast-enhanced
computed tomography (CT) after 22 months shows the patency of the superior mesenteric artery.
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initially be managed conservatively if there are no clinical
and imaging signs indicating artery rupture or intestinal
necrosis; however, regular clinical and CT follow-up are
necessary.The ﬁrst surgical treatment of isolated superior mesen-
teric artery dissection was described by Sisteron and Vie-
ville.31 Since that report, 43 patients undergoing surgical
recanalization were reported. Desirable outcome was
achieved in 42 patients. Thrombotic occlusion was presented
Fig 4. Flow diagram of treatment for isolated superior mesenteric artery dissection. CT, Computed tomography.
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bypass surgery with a saphenous graft between the superior
mesenteric artery and the right common iliac artery.
However, the patientwas asymptomatic for 5 years.32Various
surgical techniques have been reported, including aortome-
senteric bypass in nine patients, interposition graft in six,
intimectomy-patchplasty in four, bypass between the superior
mesenteric artery and right gastroepiploic artery in three,
bypass between the superior mesenteric artery and
right common iliac artery in two, the transposition of the
superior mesenteric artery to the aorta in two, intimectomy-
thrombectomy in two, thrombectomy in two, endoaneu-
rysmorrhaphy in two, endoaneurysmorrhaphy-patchplasty
in one, thrombectomy-intimectomy-aneurysmorrhaphy in
one, ligation of dissecting aneurysm in one, and venous
patchplasty in one. The operation details for the other seven
patients were unavailable. In addition, there were four
patients with enterectomy in the literature, two at the
onset18,19 and two after conservativemanagement failed.17,20
Endovascular treatment was ﬁrst reported by Leung
et al.33 Since that report, an endovascular procedure has
been used in 53 patients, of whom endovascular treat-
ment was used as primary management in 40. The other
13 patients underwent secondary endovascular treatment
after conservative management failed. The aims of endo-
vascular treatment are to seal off the false lumen and
re-establish the ﬂow. The techniques include balloon an-
gioplasty in one patient,34 embolism ruptured branch of
the superior mesenteric artery in one,19 and stent placement
in 51. Ignoring the 10 unavailable patients, self-expanding
bare stents were used in 29, balloon-expandable bare
stents in ﬁve,19 balloon-expandable covered stents in three,4
self-expanding covered stents in two,35,36 and self-
expanding and balloon-expandable stents in two.14
Stent placement can provide immediate symptom relief
with shorter fasting time37 and good long-term results were
reported in 60 of 62 patients (97%), except for two patients.In one patient reported by Kim et al,38 the recurrence of an
aneurysmal dilated false lumen was noticed 4 months after
the placement of a Wallstent (Boston Scientiﬁc, Natick,
Mass). The cause might be the proximal shortening of the
Wallstent. Next, a second SMART stent (Cordis, Miami,
Fla) was placed. In another patient reported by Yun
et al,39 the occlusion of a self-expanding nitinol stent was
revealed 17 months after placement; however, the patient
was asymptomatic. Little is known about the risk of resteno-
sis or obstruction of the stented segment. Studies with
longer follow-up periods are needed.
The indication for treatment is disputed. Min et al37
suggested the indications included severe compression of
the true lumen (>80%) and aneurysmal dilation >20 mm
in diameter. Considering the disastrous consequences of
intestinal necrosis, we conﬁrm the indications such as
abdominal pain or aneurysmal dilation >20 mm in diam-
eter. In the present study, 11 patients underwent successful
stent placement. Catheter-directed infusion of a vasodilator
was deﬁnitive management in four patients and effective
support for stent placement in 11.
By our experience, several key points should be high-
lighted. Firstly, as stenosis or occlusion of the portion of
dissection begins, the distal branches may constitute the
collateral circulation through the marginal artery and anas-
tomotic arcade. However, the isolated superior mesenteric
artery dissection can induce spasm of the distal branches
and decrease the blood ﬂow to the intestines. Catheter-
directed infusion of a vasodilator would help to relieve
spasm and increase the blood ﬂow to the intestines. Occa-
sionally, vasodilator therapy may be sufﬁcient to relieve the
symptoms, and stent placement is not needed. Vasodilator
therapy can be an effective accessional process after stent
placement in most patients.
Secondly, the guidewire should be carefully advanced
through the dissected portion into the distal trunk of the
superior mesenteric artery, without any resistance, to avoid
JOURNAL OF VASCULAR SURGERY
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and patience are necessary, especially when the superior
mesenteric artery is completely obstructed. An alternative
transmesenteric artery approach under laparotomy is occa-
sionally needed.24 One of the present patients underwent
hybrid stent placement after attempted insertion of a
guidewire into the true lumen through transfemoral ap-
proach was not successful (Fig 3). The hybrid approach
is effective and worth attempting when the ordinary
percutaneous approach is unavailable.
Thirdly, the dissection is consistently located around the
curvature of the superior mesenteric artery, which is an area
that may experience a maximal straining force. Therefore, it
is considered important that the stent completely cover the
curvature of the superior mesenteric artery.
Lastly, the stents used need good ﬂexibility and
minimal shortening and must not change location due to
the continuous movement of the mesentery. A self-
expanding stent is recommended because of its good radial
strength, ﬂexibility, conformability, and sufﬁcient length.13
Chu et al4 suggested a covered stent for isolated superior
mesenteric artery dissection with aneurysm. However,
a covered stent can result in problematic coverage of
some branches. A bare stent is sufﬁcient for total exclusion
of the aneurysm, sealing off the dissection and preserving
the branches of the superior mesenteric artery (Fig 1).
Although various therapies have been reported, there is
currently no consensus for an appropriate treatment guide-
line regarding isolated superior mesenteric artery dissection.
The management of the 296 cases of isolated superior
mesenteric artery dissection is summarized in Table II.
The efﬁciency of conservative management with anticoagu-
lation (77.2% [44 of 57]) is similar to that without antico-
agulation (73.7% [112 of 152]; P > .05). The efﬁciency of
surgical recanalization (97.0% [32 of 33]) is similar to that
of stent placement (95.2% [40 of 42]; P > .05). However,
the efﬁciency of surgical recanalization or stent placement is
signiﬁcantly better than that of conservative management,
with or without anticoagulation (P < .05). This suggests
that surgical recanalization or stent placement is more effec-
tive than conservative management. In terms of minimally
invasive procedures, we consider stent placement to be
the best option for isolated superior mesenteric artery
dissection.
CONCLUSIONS
Isolated superior mesenteric artery dissection is rare.
The dissection is always located at the anterior wall and
around the convex curvature of the superior mesenteric
artery. Contrast-enhanced CT scan is the best diagnosis
modality for isolated superior mesenteric artery dissection.
Conservative management can be applied to asymptomatic
patients, and regular clinical follow-up and CT scans are
necessary. For symptomatic patients, stent placement is
the deﬁnitive treatment if there is no arterial rupture or
intestinal necrosis, and self-expanding bare stents that
completely cover the curvature of the superior mesentericartery are recommended. Catheter-directed infusion of
a vasodilator can be an effective accessional process after
stent placement (Fig 4).AUTHOR CONTRIBUTIONS
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